...
search icon
  • Apple, Inc AAPL
  • S&P 500 ETF Trust SPDR SPY
  • Alphabet Inc. - Class A Shares GOOGL
  • Microsoft Corporation MSFT
  • Meta Platforms Inc META
  • Netflix, Inc. NFLX
  • Amazon.com Inc. AMZN
  • Spotify Technology SA SPOT
    tril-img

    Trillium Therapeutics Inc, Common Stock

    TRIL

    NMQ

    $20.11

    -$0.03

    (-0.15%)

    Industry: Biotechnology Sector: Health Care
    Overview Returns Holdings Sector Breakdown FAQs

    Key Metrics

    Expense Ratio info-icon
    The expense ratio is how much you pay a mutual fund or ETF per year, expressed as a percent of your investments. It is a measure of the fund's operating costs relative to assets.
     0
    Volume info-icon
    This is the total number of shares traded during the most recent trading day.
     102.00
    Avg Volume info-icon
    This is the average number of shares traded during the most recent 30 days.
     0
    Dividend Yield info-icon
    This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
     0.00%
    Beta info-icon
    This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
     0

    About Trillium Therapeutics Inc, Common Stock

    As of November 17, 2021, Trillium Therapeutics Inc. was acquired by Pfizer Inc. Trillium Therapeutics Inc., a clinical stage immuno-oncology company, develops therapies for the treatment of cancer. Its include TTI-622, a SIRPa-IgG4 Fc fusion protein that is designed to enhance macrophage-mediated phagocytosis and anti-tumor activity by blocking the CD47, which is in Phase 1 clinical trials; and TTI-621, a SIRPa-IgG1 Fc fusion protein, which is in Phase 1 clinical trials and generates a signal blocking the CD47 for advanced relapsed or refractory hematologic malignancies, and solid tumors and mycosis fungoides. The company was formerly known as Stem Cell Therapeutics Corp. and changed its name to Trillium Therapeutics Inc. in June 2014. Trillium Therapeutics Inc. was incorporated in 2004 is based in Cambridge, Massachusetts. more

    Industry: BiotechnologySector: Health Care

    Returns

    Time FrameTRILS&P500
    1-Week Return-1.24%
    1-Month Return-0.39%
    3-Month Return-6.79%
    6-Month Return-30.65%
    1-Year Return-15.03%
    3-Year Return-83.77%
    5-Year Return48.3%95.67%
    10-Year Return46.57%231.49%

    Sector Breakdown

    Sector Weight
    Health Care
    		100.00%

    Discover more

    spy-img

    SPDR S&P 500 ETF Trust
    qqq-img

    Invesco QQQ Trust
    vti-img

    Vanguard Total Stock Market Index Fund ETF Shares
    iefa-img

    iShares Core MSCI EAFE ETF
    bnd-img

    Vanguard Total Bond Market Index Fund ETF Shares
    ibit-img

    iShares Bitcoin Trust
    vug-img

    Vanguard Growth Index Fund ETF Shares
    gld-img

    SPDR® Gold Shares
    tlt-img

    iShares 20+ Year Treasury Bond ETF

    FAQs

    What is Trillium Therapeutics Inc (TRIL) ETF share price today?

    Trillium Therapeutics Inc (TRIL) share price today is $20.11.

    Can Indians buy Trillium Therapeutics Inc shares?

    Yes, Indians can buy shares of Trillium Therapeutics Inc (TRIL) on Vested. To buy TRIL from India, you can open a US Brokerage account by signing up on Vested. The account opening process is completely digital and secure, and takes 3-5 minutes to complete.

    Can Fractional shares of Trillium Therapeutics Inc be purchased?

    Yes, you can purchase fractional shares of Trillium Therapeutics Inc (TRIL) on Vested. You can start investing in Trillium Therapeutics Inc (TRIL) with a minimum investment of $1.

    How to invest in Trillium Therapeutics Inc shares from India?
    • Click on Sign Up or Invest in TRIL ETF at the top of this page
    • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
    • Transfer USD funds to your US Brokerage account and start investing in Trillium Therapeutics Inc shares
    What is Trillium Therapeutics Inc's ticker or symbol?

    The stock symbol (or ticker) of Trillium Therapeutics Inc is TRIL.

    Can I set up automatic investments (SIP) in Trillium Therapeutics Inc shares?

    Yes, you can setup SIP in Trillium Therapeutics Inc shares. Follow the below steps to create the SIP:

    • Sign up on Vested and complete your KYC for US Stocks
    • Transfer funds to your US Stocks account
    • Navigate to TRIL ticker page and set up your recurring investment
    What is the historical performance of Trillium Therapeutics Inc ETF?

    Here is the historical performance of TRIL on the Vested app.

    • 1-Year Return: -
    • 3-Year Return: -
    • 5-Year Return: 48.3%
    • 1-Week Return: -
    • 1-Month Return: -
    • 3-Month Return: -

    You can also access the top holdings, the expense ratio, and the sector breakdown for Trillium Therapeutics Inc on Vested.

    Feedback

    Signup to access all features and start your US investing journey!

    • Open your account in minutes
    • Take your portfolio global, starting at just $1
    Get started

    Add ticker to compare

    Scroll to Top